The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Ganesh Bio Tech India Ltd
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
BSE has received a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, filed by Suncare Traders Ltd in connection with Shree Ganesh Bio Tech India Ltd. This regulation requires reporting of changes in shareholding — such as acquisitions or disposals — that cross prescribed thresholds (typically 2% or more of voting rights) in a listed company. The actual filing details (number of shares, direction of transaction, pre/post shareholding percentages) are not available because the linked BSE page has been moved or redirected. Without the document body, the specific nature of the change in stake cannot be confirmed.
For retail investors of either Suncare Traders Ltd or Shree Ganesh Bio Tech India Ltd, this is currently uninformative because the underlying disclosure details are missing. Investors should check the latest SAST disclosure on the BSE corporate announcements page to understand whether it is a buy, sell, or change in shareholding crossing a regulatory threshold.